Search

Your search keyword '"Ohga N"' showing total 105 results

Search Constraints

Start Over You searched for: Author "Ohga N" Remove constraint Author: "Ohga N" Language english Remove constraint Language: english
105 results on '"Ohga N"'

Search Results

5. Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis.

6. Intra-articular fracture of the mandibular condyle: a case report.

7. Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells.

8. HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium.

9. Salivary miRNAs as a novel therapeutic marker in a patient with advanced oral squamous cell carcinoma: A case report.

10. Expression analysis of zinc-metabolizing enzymes in the saliva as a new method of evaluating zinc content in the body: two case reports and a review of the literature.

11. Genotypes and virulence-related activities of Candida albicans derived from oral cavity of patients in Hokkaido.

12. Potential relationship between the dosage of prednisolone and delayed healing at tooth extraction: A retrospective study.

13. Thermodynamic Bound on the Asymmetry of Cross-Correlations.

14. Information-geometric structure for chemical thermodynamics: An explicit construction of dual affine coordinates.

15. Ethyl loflazepate as a treatment for patients with idiopathic and psychogenic taste disorder.

16. Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery system.

17. Metastatic basal cell carcinoma of buccal mucosa: a report of a rare case.

18. Efficacy of rikkosan for primary burning mouth syndrome: a retrospective study.

19. Monitoring indices of bone inflammatory activity of the jaw using SPECT bone scintigraphy: a study of ARONJ patients.

20. Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw.

21. The identification of autoantigens in mucous membrane pemphigoid using immortalized oral mucosal keratinocytes.

22. Mucosal substrates successfully identify the autoantigen in a case of mucous membrane pemphigoid.

24. Successful conservative treatment of jaw osteonecrosis caused by denosumab in patients with multiple bone metastasis.

25. Tumor endothelial cells with high aldehyde dehydrogenase activity show drug resistance.

26. 18 F-Fluoromisonidazole positron emission tomography (FMISO-PET) may reflect hypoxia and cell proliferation activity in oral squamous cell carcinoma.

27. Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study.

28. miR-145 promoted anoikis resistance in tumor endothelial cells.

29. ROS enhance angiogenic properties via regulation of NRF2 in tumor endothelial cells.

30. Vasohibin-1 as a Novel Prognostic Factor for Head and Neck Squamous Cell Carcinoma.

31. Unusual maxillary osteoblastic and osteolytic lesions presenting as an initial manifestation of childhood acute myeloid leukemia: A case report.

32. Tumor endothelial cells express high pentraxin 3 levels.

33. Elimination of oral candidiasis may increase stimulated whole salivary flow rate.

34. Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan.

35. CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property.

36. Differences in sequential posttreatment salivary IL-6 levels between patients with and patients without locoregional recurrences of oral squamous cell carcinoma: Part III of a cohort study.

37. Healing of osteonecrosis of the jaw (ONJ) after discontinuation of denosumab in a patient with bone metastases of colorectal cancer: a case report and hypothesis.

38. Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxel.

39. Identification of tumor endothelial cells with high aldehyde dehydrogenase activity and a highly angiogenic phenotype.

40. Suprabasin as a novel tumor endothelial cell marker.

41. Ligand density at the surface of a nanoparticle and different uptake mechanism: two important factors for successful siRNA delivery to liver endothelial cells.

42. Identification and expression of troponin T, a new marker on the surface of cultured tumor endothelial cells by aptamer ligand.

43. An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells.

44. Identification of novel targets for antiangiogenic therapy by comparing the gene expressions of tumor and normal endothelial cells.

45. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.

46. Construction of an aptamer modified liposomal system targeted to tumor endothelial cells.

47. Hypoxia-induced reactive oxygen species cause chromosomal abnormalities in endothelial cells in the tumor microenvironment.

48. A liposomal delivery system that targets liver endothelial cells based on a new peptide motif present in the ApoB-100 sequence.

49. Heterogeneity of tumor endothelial cells.

50. Application of POLARIC™ fluorophores in an in vivo tumor model.

Catalog

Books, media, physical & digital resources